Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nanobiotix S.A. ADR (NBTX)

Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Nanobiotix Updates Voting Rights and Share Capital Details

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nanobiotix...

NBTX : 32.08 (-5.65%)
Stifel Nicolaus Remains a Buy on Nanobiotix (0QAV)

Stifel Nicolaus analyst Clémence Thiers maintained a Buy rating on Nanobiotix today and set a price target of €25.00. The company’s shares opened today at €18.10.Elevate Your Investing Strategy:...

NBTX : 32.08 (-5.65%)
Jefferies Reaffirms Their Buy Rating on Nanobiotix (0QAV)

Jefferies analyst Lucy Codrington maintained a Buy rating on Nanobiotix today and set a price target of €21.00. The company’s shares opened today at €17.06.Elevate Your Investing Strategy: Take advantage...

NBTX : 32.08 (-5.65%)
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances

Nanobiotix Sa ADR ( (NBTX) ) has released its Q2 earnings. Here is a breakdown of the information Nanobiotix Sa ADR presented to its investors.Elevate Your Investing Strategy: Take advantage of TipRanks...

NBTX : 32.08 (-5.65%)
Nanobiotix Reports Promising Phase 1 Results for Esophageal Cancer Treatment

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nanobiotix...

NBTX : 32.08 (-5.65%)
Nanobiotix: Voting Rights and Shares Capital of the Company

Regulatory News:

NANO : 35.33 (-0.81%)
NBTX : 32.08 (-5.65%)
Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022

Regulatory News:

NBTX : 32.08 (-5.65%)
Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022

Regulatory News:

NBTX : 32.08 (-5.65%)
Nanobiotix Establishes Recommended Dose for Planned Registrational Study Evaluating NBTXR3 Plus Anti-PD-1 for Patients With Metastatic Head and Neck Cancer Resistant to Prior Immunotherapy

Regulatory News:

NBTX : 32.08 (-5.65%)

Barchart Exclusives

As Applied Materials Raises Its Dividend 15%, Should You Buy AMAT Stock?
Applied Materials' 15% dividend hike to $0.53 per share, backed by a forward payout ratio of under 19% and an 18% annualized growth rate over the past decade, signals a company confident enough in its AI memory and logic tool cycle to keep rewarding shareholders. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar